Please login to the form below

Not currently logged in
Email:
Password:

collaboration

This page shows the latest collaboration news and features for those working in and with pharma, biotech and healthcare.

BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC

BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC

added. In January, Novartis and BeiGene signed a strategic collaboration agreement for the Swiss pharma company to in-license tislelizumab in ‘major markets’ outside of China.

Latest news

More from news
Approximately 91 fully matching, plus 1,601 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 52 fully matching, plus 315 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 67 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 26 fully matching, plus 213 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics